Small-colony variants and phenotype switching of intracellular Staphylococcus aureus in chronic rhinosinusitis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 69, Issue 10, 2014, Pages 1364-1371

  Tan, N C W ^a   Cooksley, C M ^a   Roscioli, E ^a   Drilling, A J ^a   Douglas, R ^b   Wormald, P J ^a   Vreugde, S ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Chronic rhinosinusitis; Intracellular infection; Phenotype switching; Small colony variant; Staphylococcus aureus

Indexed keywords

COAGULASE; ENTEROTOXIN; INTERLEUKIN 6;

ADULT; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM COLONY; CHRONIC RHINOSINUSITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INTERNALIZATION; PHENOTYPE; PULSED FIELD GEL ELECTROPHORESIS; REAL TIME POLYMERASE CHAIN REACTION; SMALL COLONY VARIANT; STAPHYLOCOCCUS AUREUS; TISSUE HOMOGENATE; FEMALE; GROWTH, DEVELOPMENT AND AGING; MALE; MICROBIOLOGY; NOSE MUCOSA; RHINITIS; SINUSITIS; STAPHYLOCOCCUS INFECTION;

ADULT; FEMALE; HUMANS; MALE; NASAL MUCOSA; PHENOTYPE; RHINITIS; SINUSITIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84907954236     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12457     Document Type: Article

References (32)

1. Rosenfeld RM, Andes D, Bhattacharyya N, Cheung D, Eisenberg S, Ganiats TG et al. Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg 2007;137(3 Suppl):S1-S31.
2. Anand VK. Epidemiology and economic impact of rhinosinusitis. Ann Otol Rhinol Laryngol Suppl 2004;193:3-5.
3. Jervis-Bardy J, Foreman A, Field J, Wormald PJ. Impaired mucosal healing and infection associated with Staphylococcus aureus after endoscopic sinus surgery. Am J Rhinol Allergy 2009;23:549-552.
4. Videler WJ, Badia L, Harvey RJ, Gane S, Georgalas C, van der Meulen FW et al. Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trial. Allergy 2011;66:1457-1468.
5. Foreman A, Jervis-Bardy J, Wormald PJ. Do biofilms contribute to the initiation and recalcitrance of chronic rhinosinusitis? Laryngoscope 2011;121:1085-1091.
6. Tan NC, Foreman A, Jardeleza C, Douglas R, Vreugde S, Wormald PJ. Intracellular Staphylococcus aureus: the Trojan horse of recalcitrant chronic rhinosinusitis? Int Forum Allergy Rhinol 2013;3:261-266.
7. Sachse F, Becker K, von Eiff C, Metze D, Rudack C. Staphylococcus aureus invades the epithelium in nasal polyposis and induces IL-6 in nasal epithelial cells in vitro. Allergy 2010;65:1430-1437.
8. Corriveau MN, Zhang N, Holtappels G, Van Roy N, Bachert C. Detection of Staphylococcus aureus in nasal tissue with peptide nucleic acid-fluorescence in situ hybridization. Am J Rhinol Allergy 2009;23:461-465.
9. Plouin-Gaudon I, Clement S, Huggler E, Chaponnier C, Francois P, Lew D et al. Intracellular residency is frequently associated with recurrent Staphylococcus aureus rhinosinusitis. Rhinology 2006;44:249-254.
10. Clement S, Vaudaux P, Francois P, Schrenzel J, Huggler E, Kampf S et al. Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis. J Infect Dis 2005;192:1023-1028.
11. Tan NC, Foreman A, Jardeleza C, Douglas R, Tran H, Wormald PJ. The multiplicity of Staphylococcus aureus in chronic rhinosinusitis: correlating surface biofilm and intracellular residence. Laryngoscope 2012;122:1655-1660.
12. Jardeleza C, Miljkovic D, Baker L, Boase S, Tan NC, Koblar SA et al. Inflammasome gene expression alterations in Staphylococcus aureus biofilm-associated chronic rhinosinusitis. Rhinology 2013;51:315-322.
13. Ellington JK, Harris M, Webb L, Smith B, Smith T, Tan K et al. Intracellular Staphylococcus aureus. A mechanism for the indolence of osteomyelitis. J Bone Joint Surg Br 2003;85:918-921.
14. Sinha B, Herrmann M. Mechanism and consequences of invasion of endothelial cells by Staphylococcus aureus. Thromb Haemost 2005;94:266-277.
15. Kahl B, Herrmann M, Everding AS, Koch HG, Becker K, Harms E et al. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis 1998;177:1023-1029.
16. Proctor RA, von Eiff C, Kahl BC, Becker K, McNamara P, Herrmann M et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 2006;4:295-305.
17. Vaudaux P, Francois P, Bisognano C, Kelley WL, Lew DP, Schrenzel J et al. Increased expression of clumping factor and fibronectin-binding proteins by hemB mutants of Staphylococcus aureus expressing small colony variant phenotypes. Infect Immun 2002;70:5428-5437.
18. Balwit JM, van Langevelde P, Vann JM, Proctor RA. Gentamicin-resistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells. J Infect Dis 1994;170:1033-1037.
19. Seiberling KA, Grammer L, Kern RC. Chronic rhinosinusitis and superantigens. Otolaryngol Clin North Am 2005;38:1215-1236.
20. Clark DW, Wenaas A, Citardi MJ, Luong A, Fakhri S. Chronic rhinosinusitis with nasal polyps: elevated serum immunoglobulin E is associated with Staphylococcus aureus on culture. Int Forum Allergy Rhinol 2011;1:445-450.
21. Tomassen P, Jarvis D, Newson R, Van Ree R, Forsberg B, Howarth P et al. Staphylococcus aureus enterotoxin-specific IgE is associated with asthma in the general population: a GA(2)LEN study. Allergy 2013;68:1289-1297.
22. Bachert C, Gevaert P, Holtappels G, Johansson SG, van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001;107:607-614.
23. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology 2012; 50:1-12.
24. Kaufmann ME. Pulsed-field gel electrophoresis. In: Woodford N, Johnson A, editors. Molecular Bacteriology: Protocols and Clinical Applications, vol 1. Totowa, NJ: Humana Press, 1998:33-51.
25. Kipp F, Kahl BC, Becker K, Baron EJ, Proctor RA, Peters G et al. Evaluation of two chromogenic agar media for recovery and identification of Staphylococcus aureus small-colony variants. J Clin Microbiol 2005;43:1956-1959.
26. Tuchscherr L, Medina E, Hussain M, Volker W, Heitmann V, Niemann S et al. Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol Med 2011;3:129-141.
27. Bester E, Wolfaardt G, Joubert L, Garny K, Saftic S. Planktonic-cell yield of a pseudomonad biofilm. Appl Environ Microbiol 2005;71:7792-7798.
28. Foreman A, Wormald PJ. Different biofilms, different disease? A clinical outcomes study Laryngoscope 2010;120:1701-1706.
29. Garcia LG, Lemaire S, Kahl BC, Becker K, Proctor RA, Denis O et al. Antibiotic activity against small-colony variants of Staphylococcus aureus: review of in vitro, animal and clinical data. J Antimicrob Chemother 2013;68:1455-1464.
30. Edwards AM. Phenotype switching is a natural consequence of Staphylococcus aureus replication. J Bacteriol 2012;194:5404-5412.
31. Kim MR, Hong SW, Choi EB, Lee WH, Kim YS, Jeon SG et al. Staphylococcus aureus-derived extracellular vesicles induce neutrophilic pulmonary inflammation via both Th1 and Th17 cell responses. Allergy 2012;67:1271-1281.
32. Hartung T, Daston G. Are in vitro tests suitable for regulatory use? Toxicol Sci 2009;111:233-237.